FDA permits emergency use of flu drugs, diagnostic test

04/27/2009 | Reuters · Wall Street Journal, The

The FDA has signed emergency authorizations for unapproved uses of GlaxoSmithKline's Relenza, Roche Holding's Tamiflu and the rRT-PCR Swine Flu Panel diagnostic test in response to the public health emergency declared amid the swine flu outbreak. The swine flu strain reportedly has infected more than 40 people in the U.S.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC